Skip to main navigation Skip to search Skip to main content

Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid

  • S. F. L. van Lelyveld
  • , M. Nijhuis
  • , F. Baatz
  • , I. Wilting
  • , W. M. van den Bergh
  • , M. Kurowski
  • , D. de Jong
  • , A. I. M. Hoepelman
  • , A. M. J. Wensing

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We report the selection of enfuvirtide-resistant human immunodeficiency virus type 1 in cerebrospinal fluid, resulting in subsequent loss of viral suppression in the plasma. This case report emphasizes the potential danger of low-level penetration of entry inhibitors into the central nervous system
Original languageEnglish
Pages (from-to)387-390
JournalClinical infectious diseases
Volume50
Issue number3
DOIs
Publication statusPublished - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid'. Together they form a unique fingerprint.

Cite this